Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism

Fertility and sterility, 78(6), 1331-1333

DOI 10.1016/s0015-0282(02)04294-2 PMID 12477537 Source

Abstract

Hirsutism is a very common clinical problem encountered in daily practice, and, unfortunately, its treatment is far from satisfactory. In several studies, antiandrogens were given in combination with oral contraceptives (1–3), however, there are not enough data about the effects of combination therapy of antiandrogens in women with hirsutism. Thirty-four patients were recruited into the study from the Endocrinology Outpatient Clinic of Erciyes University Hospital. Each patient gave informed consent, and the study was approved by the ethics committee and Institutional Review Board of Erciyes University. Cushing’s syndrome, nonclassic adrenal hyperplasia, androgen-secreting tumors, and prolactinoma were excluded by appropriate tests and radiological investiga- tions. Twelve patients were oligomenorrheic, and these patients had polycystic ovary syndrome. Twenty-two patients had idiopathic hirsutism.

Topics

spironolactone hirsutism treatment, finasteride for excess hair growth, antiandrogen therapy hirsutism, PCOS hirsutism management, idiopathic hirsutism treatment, combination antiandrogen therapy, spironolactone finasteride combination, hyperandrogenism treatment options, unwanted hair growth treatment, polycystic ovary syndrome hair removal

Cite this article

Unlühizarci K, K., Everest, H., Bayram, F., & Keleştimur, F. (2002). Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism. *Fertility and sterility*, *78*(6), 1331-1333. https://doi.org/10.1016/s0015-0282(02)04294-2

Related articles